| Protein Name | SMAD Family Member 3 |
| Gene | SMAD3 |
| UniProt ID | P84022 |
| PDB IDs | 1MK2, 1MKS, 1OZ1 |
| Molecular Weight | 48 kDa |
| Subcellular Localization | Cytoplasm, nucleus |
| Protein Family | SMAD family |
SMAD Family Member 3 is a SMAD family member. The protein contains the characteristic domain structure including [domain descriptions]. The molecular weight is approximately 48 kDa, and the protein localizes to Cytoplasm, nucleus.
SMAD3 is a receptor-regulated SMAD (R-SMAD) that mediates TGF-β signaling. Upon TGF-β receptor activation, SMAD3 is phosphorylated, forms a complex with SMAD4, and translocates to the nucleus where it regulates gene transcription. SMAD3 has diverse functions in cell proliferation, differentiation, apoptosis, and extracellular matrix production. In the nervous system, SMAD3 regulates neurogenesis, synaptic plasticity, astrocyte reactivity, and neuroinflammation. It plays complex roles in neural development and adult brain function.
SMAD3 is implicated in ALS (mutations cause a subset of cases), Alzheimer's disease, and Parkinson's disease. SMAD3 dysregulation contributes to fibrosis in multiple organs. Loeys-Dietz syndrome type 3 is caused by SMAD3 mutations.
This protein is a potential therapeutic target for neurodegenerative diseases. Research is ongoing to develop small molecule inhibitors and biologics that modulate its activity.
This section provides background information on the gene/protein and its role in the nervous system.
This overview section needs to be expanded with relevant scientific information from peer-reviewed sources.